Kevin A Hildebrand Selected Research

Contracture

1/2021	The Dose-Response Effect of the Mast Cell Stabilizer Ketotifen Fumarate on Posttraumatic Joint Contracture: An in Vivo Study in a Rabbit Model.
12/2020	PrEvention of Posttraumatic contractuRes with Ketotifen 1 (PERK 1): A Randomized Clinical Trial.
2/2020	PrEvention of posttraumatic contractuRes with Ketotifen 2 (PERK 2) - protocol for a multicenter randomized clinical trial.
1/2020	Human serum mast cell tryptase levels in elbow fractures or dislocations and its association with injury severity.
3/2017	Serum Mast Cell Tryptase as a Marker of Posttraumatic Joint Contracture in a Rabbit Model.
10/2014	A myofibroblast-mast cell-neuropeptide axis of fibrosis in post-traumatic joint contractures: an in vitro analysis of mechanistic components.
11/2013	Posttraumatic elbow contractures: targeting neuroinflammatory fibrogenic mechanisms.
11/2013	Posttraumatic elbow joint contractures: defining pathologic capsular mechanisms and potential future treatment paradigms.
4/2012	The mast cell stabilizer ketotifen reduces joint capsule fibrosis in a rabbit model of post-traumatic joint contractures.
6/2010	The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin A Hildebrand Research Topics

Disease

17	Contracture 01/2021 - 02/2004
7	Fibrosis (Cirrhosis) 02/2020 - 03/2008
2	Elbow Fractures 12/2020 - 01/2020
2	Wounds and Injuries (Trauma) 01/2020 - 03/2008
1	Rupture 10/2021
1	Infections 01/2017
1	Rheumatoid Arthritis 01/2017
1	Tendon Injuries 11/2010
1	Hyperplasia 06/2010

Drug/Important Bio-Agent (IBA)

7	Ketotifen (Ketotifene)FDA Link 01/2021 - 03/2008
5	Mast Cell StabilizersIBA 01/2021 - 03/2008
5	NeuropeptidesIBA 02/2020 - 10/2008
5	CollagenIBA 04/2012 - 10/2005
5	Messenger RNA (mRNA)IBA 04/2012 - 10/2005
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2013 - 03/2007
3	Tryptases (Tryptase)IBA 01/2020 - 04/2012
2	Substance PIBA 01/2021 - 11/2013
2	Proteins (Proteins, Gene)FDA Link 04/2012 - 02/2004
2	DecorinIBA 05/2006 - 10/2005
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Nerve Growth Factor (NGF)IBA 11/2013
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2013
1	Connective Tissue Growth FactorIBA 03/2007
1	Fibronectins (Fibronectin)IBA 03/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2007
1	LumicanIBA 05/2006
1	Tissue Inhibitor of Metalloproteinase-1IBA 05/2006
1	Matrix Metalloproteinases (MMPs)IBA 10/2005
1	BiglycanIBA 10/2005
1	Capsules (Microcapsules)IBA 02/2004

Therapy/Procedure

2	Therapeutics 03/2017 - 02/2004
1	Early Ambulation 10/2021
1	Activities of Daily Living (ADL) 01/2021
1	Replantation 01/2017
1	Arthroplasty 01/2017
1	Sutures (Suture) 11/2010